Taro Pharmaceutical Industries (TARO)
Add to Watchlists Create an Alert
63.02
-0.80 -1.25%
NYSE
May 23, 5:00PM
BATS Real time
Currency in USD
Taro Pharmaceutical Industries Debt to Equity Ratio:
0.0336 for Dec. 31, 2012Taro Pharmaceutical Industries Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.0336 |
| Sept. 30, 2012 | 0.0497 |
| June 30, 2012 | 0.0551 |
| March 31, 2012 | 0.0629 |
| Dec. 31, 2011 | 0.0875 |
| Sept. 30, 2011 | 0.1133 |
| June 30, 2011 | 0.1327 |
| March 31, 2011 | 0.151 |
| Dec. 31, 2010 | 0.1783 |
| Sept. 30, 2010 | 0.443 |
| June 30, 2010 | 0.5598 |
| March 31, 2010 | |
| Dec. 31, 2009 | 0.5589 |
| Sept. 30, 2009 | 0.7668 |
| June 30, 2009 | 0.8052 |
| March 31, 2009 | 0.9249 |
| Dec. 31, 2008 | 1.145 |
| Sept. 30, 2008 | 1.028 |
| June 30, 2008 | |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
| June 30, 2000 | Go Pro |
| March 31, 2000 | Go Pro |
| Dec. 31, 1999 | Go Pro |
| Sept. 30, 1999 | Go Pro |
| June 30, 1999 | Go Pro |
| March 31, 1999 | Go Pro |
| Dec. 31, 1998 | Go Pro |
| Sept. 30, 1998 | Go Pro |
| June 30, 1998 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
TARO Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Perrigo Company | 0.6194 |
| Valeant Pharmaceuticals International | 2.960 |
| Pernix Therapeutics | 0.5556 |
TARO Debt to Equity Ratio Rankings
| Overall |
80th percentile 1555 of 8006 |
| Sector |
63rd percentile 252 of 686 in Healthcare |
| Industry |
57th percentile 29 of 68 in Drug Manufacturers - Specialty & Generic |
TARO Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.0336 | Dec 2012 |
| Maximum | 1.145 | Dec 2008 |
| Average | 0.4174 |